Director, Strategy & Business Development

Scorpion Therapeutics; United States; On-site; USD 236,000 - 275,000; Full time

Benefits offered by this job

Equity (options/RSUs)

Health/dental/vision

401k match

Learning stipend

Wellness stipend

Paid time off

Job summary

Scorpion Therapeutics is seeking an experienced business/strategy professional to lead BD forecasting, valuation modeling, and enterprise planning in a US-based, on-site role in South San Francisco. You will build top-down drug revenue models, test commercial assumptions, and support AI-enabled initiatives across leadership teams.

The position emphasizes strong financial modeling, executive communication, and cross-functional collaboration with Finance, R&D, and Commercial.

Qualifications

• 4–7+ years in strategy consulting, investment banking, corporate strategy, or biotech/pharma BD.
• Ability to build top-down drug revenue/commercial models from epidemiology, pricing, and uptake assumptions.
• Quantitative/financial modeling skills (rNPV, DCF, comparable transactions, scenario/sensitivity).
• Structured, decision-ready recommendations for ambiguous problems.
• AI-capable: LLM tooling, prompt engineering, lightweight automations; take use case from POC to adoption.
• Excellent executive communication; credibility with senior leaders/Board.
• Therapeutic fluency (cardiovascular/rare disease a plus).

Responsibilities

• Own and build first-pass, top-down drug revenue forecasts translating epidemiology, diagnosis and treatment rates, pricing, and penetration/peak-share assumptions into commercial forecasts.
• Develop and apply valuation models based on forecasts (rNPV, scenario and sensitivity analysis), including out-licensing/deal modeling; translate outputs into implications, trade-offs, and recommendations.
• Challenge and pressure-test commercial assumptions to strengthen forecast/valuation quality and BD decision-making.
• Continuously improve reusable forecast, valuation, comps, and screening templates.
• Support ad-hoc BD analysis and tooling (e.g., asset-identification screens across scientific-congress datasets).
• Support annual strategic planning cycle and August Board presentation end-to-end (narrative, analysis, synthesis).
• Own and improve cross-functional planning inputs/templates across Finance, R&D, and Commercial.
• Support program management for AI ambition: intake/triage, prioritization, cadence, and governance development support with IT across COC/SLT/Executive Committee.
• Build templates and enablement for “AI champions”; maintain repository of AI use cases.
• Coordinate AI content for leadership and Board materials.
• Deliver ad-hoc executive analyses including MFN and drug-pricing differential analysis; red-team.

Skills

Strategy consulting

Investment banking

Corporate strategy

Biotech/Pharma BD

MBA/PhD/MD

Financial modeling

Executive communication

AI tooling

Therapeutic fluency

Education

MBA/PhD/MD

Tools

LLM tooling

Prompt engineering

Job description

Key Responsibilities

Business development support & drug forecasting

• Own and build first-pass, top-down drug revenue forecasts translating epidemiology, diagnosis and treatment rates, pricing, and penetration/peak-share assumptions into commercial forecasts.
• Develop and apply valuation models based on forecasts (rNPV, scenario and sensitivity analysis), including out-licensing/deal modeling; translate outputs into implications, trade-offs, and recommendations.
• Challenge and pressure-test commercial assumptions to strengthen forecast/valuation quality and BD decision-making.
• Continuously improve reusable forecast, valuation, comps, and screening templates.
• Support ad-hoc BD analysis and tooling (e.g., asset-identification screens across scientific-congress datasets).

Enterprise strategy & planning

• Support annual strategic planning cycle and August Board presentation end-to-end (narrative, analysis, synthesis).
• Own and improve cross-functional planning inputs/templates across Finance, R&D, and Commercial.

Enterprise AI as a strategic initiative

• Support program management for AI ambition: intake/triage, prioritization, cadence, and governance development support with IT across COC/SLT/Executive Committee.
• Build templates and enablement for “AI champions”; maintain repository of AI use cases.
• Coordinate AI content for leadership and Board materials.

CSC & Board analytics

• Deliver ad-hoc executive analyses including MFN and drug-pricing differential analysis; red-team.

Qualifications

• 4–7+ years in strategy consulting, investment banking, corporate strategy, or biotech/pharma BD; MBA/PhD/MD or equivalent a plus.
• Ability to build top-down drug revenue/commercial models from epidemiology, pricing, and uptake assumptions.
• Quantitative/financial modeling skills (rNPV, DCF, comparable transactions, scenario/sensitivity).
• Structured, decision-ready recommendations for ambiguous problems.
• AI-capable: LLM tooling, prompt engineering, lightweight automations; take use case from POC to adoption.
• Excellent executive communication; credibility with senior leaders/Board.
• Therapeutic fluency (cardiovascular/rare disease a plus).

Location: On-site, South San Francisco, CA; at least 4 days onsite each week.

Pay Range: $235,800–$275,100 base; benefits include equity (options/RSUs), health/dental/vision/life/disability, 401k match, learning & wellness stipends, and paid time off.